Compare · MOTS vs SYK
MOTS vs SYK
Side-by-side comparison of Motus GI Holdings Inc. (MOTS) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MOTS and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK carries a market cap of $118.01B.
- SYK has hit the wire 6 times in the past 4 weeks while MOTS has been quiet.
- SYK has more recent analyst coverage (25 ratings vs 1 for MOTS).
- Company
- Motus GI Holdings Inc.
- Stryker Corporation
- Price
- -
- -
- Market cap
- -
- $118.01B
- 1M return
- -
- +0.99%
- 1Y return
- -
- -16.21%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- News (4w)
- 0
- 6
- Recent ratings
- 1
- 25
Motus GI Holdings Inc.
Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest MOTS
- Amendment: SEC Form SC 13G/A filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form 15-12G filed by Motus GI Holdings Inc.
- SEC Form S-8 POS filed by Motus GI Holdings Inc.
- SEC Form S-8 POS filed by Motus GI Holdings Inc.
- SEC Form S-8 POS filed by Motus GI Holdings Inc.
Latest SYK
- Director Ronda E Stryker exercised 3,605 shares at a strike of $122.51, increasing direct ownership by 473% to 4,367 units (SEC Form 4)
- Director Stryker Ronda E sold $178,924,731 worth of shares (550,000 units at $325.32) (SEC Form 4)
- Stryker Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Stryker announces intention to nominate Jim Davis to board of directors
- What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street
- SEC Form S-3ASR filed by Stryker Corporation
- SEC Form IRANNOTICE filed by Stryker Corporation
- SEC Form 10-Q filed by Stryker Corporation
- Stryker downgraded by Canaccord Genuity with a new price target
- SEC Form 8-K filed by Stryker Corporation